Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
07 2022
Historique:
received: 13 08 2021
accepted: 09 05 2022
pubmed: 18 6 2022
medline: 16 7 2022
entrez: 17 6 2022
Statut: ppublish

Résumé

More than 800 million people suffer from kidney disease, yet the mechanism of kidney dysfunction is poorly understood. In the present study, we define the genetic association with kidney function in 1.5 million individuals and identify 878 (126 new) loci. We map the genotype effect on the methylome in 443 kidneys, transcriptome in 686 samples and single-cell open chromatin in 57,229 kidney cells. Heritability analysis reveals that methylation variation explains a larger fraction of heritability than gene expression. We present a multi-stage prioritization strategy and prioritize target genes for 87% of kidney function loci. We highlight key roles of proximal tubules and metabolism in kidney function regulation. Furthermore, the causal role of SLC47A1 in kidney disease is defined in mice with genetic loss of Slc47a1 and in human individuals carrying loss-of-function variants. Our findings emphasize the key role of bulk and single-cell epigenomic information in translating genome-wide association studies into identifying causal genes, cellular origins and mechanisms of complex traits.

Identifiants

pubmed: 35710981
doi: 10.1038/s41588-022-01097-w
pii: 10.1038/s41588-022-01097-w
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

950-962

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK050306
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK105821
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK087635
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK076077
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709–733 (2020).
doi: 10.1016/S0140-6736(20)30045-3
Kottgen, A. et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat. Genet. 41, 712–717 (2009).
pubmed: 19430482 pmcid: 3039280 doi: 10.1038/ng.377
Pattaro, C. et al. Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat. Commun. 7, 10023 (2016).
pubmed: 26831199 pmcid: 4735748 doi: 10.1038/ncomms10023
Wuttke, M. et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat. Genet. 51, 957–972 (2019).
pubmed: 31152163 pmcid: 6698888 doi: 10.1038/s41588-019-0407-x
Hellwege, J. N. et al. Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program. Nat. Commun. 10, 3842 (2019).
pubmed: 31451708 pmcid: 6710266 doi: 10.1038/s41467-019-11704-w
Sullivan, K. M. & Susztak, K. Unravelling the complex genetics of common kidney diseases: from variants to mechanisms. Nat. Rev. Nephrol. 16, 628–640 (2020).
pubmed: 32514149 pmcid: 8014547 doi: 10.1038/s41581-020-0298-1
Qiu, C. et al. Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease. Nat. Med. 24, 1721–1731 (2018).
pubmed: 30275566 pmcid: 6301011 doi: 10.1038/s41591-018-0194-4
GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318–1330 (2020).
doi: 10.1126/science.aaz1776
Ko, Y. A. et al. Genetic-variation-driven gene-expression changes highlight genes with important functions for kidney disease. Am. J. Hum. Genet. 100, 940–953 (2017).
pubmed: 28575649 pmcid: 5473735 doi: 10.1016/j.ajhg.2017.05.004
Gillies, C. E. et al. An eQTL landscape of kidney tissue in human nephrotic syndrome. Am. J. Hum. Genet. 103, 232–244 (2018).
pubmed: 30057032 pmcid: 6081280 doi: 10.1016/j.ajhg.2018.07.004
Sheng, X. et al. Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatments. Nat. Genet. 53, 1322–1333 (2021).
pubmed: 34385711 doi: 10.1038/s41588-021-00909-9
Yao, D. W., O’Connor, L. J., Price, A. L. & Gusev, A. Quantifying genetic effects on disease mediated by assayed gene expression levels. Nat. Genet. 52, 626–633 (2020).
pubmed: 32424349 pmcid: 7276299 doi: 10.1038/s41588-020-0625-2
Reik, W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447, 425–432 (2007).
pubmed: 17522676 doi: 10.1038/nature05918
Boix, C. A., James, B. T., Park, Y. P., Meuleman, W. & Kellis, M. Regulatory genomic circuitry of human disease loci by integrative epigenomics. Nature 590, 300–307 (2021).
pubmed: 33536621 pmcid: 7875769 doi: 10.1038/s41586-020-03145-z
Jones, P. A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484–492 (2012).
pubmed: 22641018 doi: 10.1038/nrg3230
Ziller, M. J. et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 500, 477–481 (2013).
pubmed: 23925113 pmcid: 3821869 doi: 10.1038/nature12433
Hannon, E. et al. Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci. Nat. Neurosci. 19, 48–54 (2016).
pubmed: 26619357 doi: 10.1038/nn.4182
Chen, L. et al. Genetic drivers of epigenetic and transcriptional variation in human immune cells. Cell 167, 1398–1414 e24 (2016).
pubmed: 27863251 pmcid: 5119954 doi: 10.1016/j.cell.2016.10.026
Taylor, D. L. et al. Integrative analysis of gene expression, DNA methylation, physiological traits, and genetic variation in human skeletal muscle. Proc. Natl Acad. Sci. USA 116, 10883–10888 (2019).
pubmed: 31076557 pmcid: 6561151 doi: 10.1073/pnas.1814263116
Wojcik, G. L. et al. Genetic analyses of diverse populations improves discovery for complex traits. Nature 570, 514–518 (2019).
pubmed: 31217584 pmcid: 6785182 doi: 10.1038/s41586-019-1310-4
van Zuydam, N. R. et al. A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes. Diabetes 67, 1414–1427 (2018).
pubmed: 29703844 pmcid: 6014557 doi: 10.2337/db17-0914
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
pubmed: 20616382 pmcid: 2922887 doi: 10.1093/bioinformatics/btq340
Sinnott-Armstrong, N. et al. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nat. Genet. 53, 185–194 (2021).
pubmed: 33462484 doi: 10.1038/s41588-020-00757-z
Stanzick, K. J. et al. Discovery and prioritization of variants and genes for kidney function in >1.2 million individuals. Nat. Commun. 12, 4350 (2021).
pubmed: 34272381 pmcid: 8285412 doi: 10.1038/s41467-021-24491-0
Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628–634 (2021).
pubmed: 34662886 pmcid: 8596853 doi: 10.1038/s41586-021-04103-z
Barton, A. R., Sherman, M. A., Mukamel, R. E. & Loh, P. R. Whole-exome imputation within UK Biobank powers rare coding variant association and fine-mapping analyses. Nat. Genet. 53, 1260–1269 (2021).
pubmed: 34226706 pmcid: 8349845 doi: 10.1038/s41588-021-00892-1
Kaushal, G. P., Haun, R. S., Herzog, C. & Shah, S. V. Meprin A metalloproteinase and its role in acute kidney injury. Am. J. Physiol. Renal Physiol. 304, F1150–F1158 (2013).
pubmed: 23427141 pmcid: 3651633 doi: 10.1152/ajprenal.00014.2013
Wen, X. et al. Transgenic expression of the human MRP2 transporter reduces cisplatin accumulation and nephrotoxicity in Mrp2-null mice. Am. J. Pathol. 184, 1299–1308 (2014).
pubmed: 24641901 pmcid: 4005989 doi: 10.1016/j.ajpath.2014.01.025
Lu, W. et al. NFIA haploinsufficiency is associated with a CNS malformation syndrome and urinary tract defects. PLoS Genet. 3, e80 (2007).
pubmed: 17530927 pmcid: 1877820 doi: 10.1371/journal.pgen.0030080
Eales, J. M. et al. Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidney. Nat. Genet. 53, 630–637 (2021).
pubmed: 33958779 doi: 10.1038/s41588-021-00835-w
Chambers, B. E. et al. Tfap2a is a novel gatekeeper of nephron differentiation during kidney development. Development 146, dev172387 (2019).
pubmed: 31160420 pmcid: 6633607 doi: 10.1242/dev.172387
Jonker, J. W., Wagenaar, E., Van Eijl, S. & Schinkel, A. H. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations. Mol. Cell Biol. 23, 7902–7908 (2003).
pubmed: 14560032 pmcid: 207626 doi: 10.1128/MCB.23.21.7902-7908.2003
Sheng, X. et al. Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease. Proc. Natl Acad. Sci. USA 117, 29013–29024 (2020).
pubmed: 33144501 pmcid: 7682409 doi: 10.1073/pnas.2005905117
Delahaye, F. et al. Genetic variants influence on the placenta regulatory landscape. PLoS Genet. 14, e1007785 (2018).
pubmed: 30452450 pmcid: 6277118 doi: 10.1371/journal.pgen.1007785
Husquin, L. T. et al. Exploring the genetic basis of human population differences in DNA methylation and their causal impact on immune gene regulation. Genome Biol. 19, 222 (2018).
pubmed: 30563547 pmcid: 6299574 doi: 10.1186/s13059-018-1601-3
Bonder, M. J. et al. Disease variants alter transcription factor levels and methylation of their binding sites. Nat. Genet. 49, 131–138 (2017).
pubmed: 27918535 doi: 10.1038/ng.3721
Loh, P. R., Kichaev, G., Gazal, S., Schoech, A. P. & Price, A. L. Mixed-model association for biobank-scale datasets. Nat. Genet. 50, 906–908 (2018).
pubmed: 29892013 pmcid: 6309610 doi: 10.1038/s41588-018-0144-6
Hekselman, I. & Yeger-Lotem, E. Mechanisms of tissue and cell-type specificity in heritable traits and diseases. Nat. Rev. Genet. 21, 137–150 (2020).
pubmed: 31913361 doi: 10.1038/s41576-019-0200-9
Roadmap Epigenomics Consortium et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).
pmcid: 4530010 doi: 10.1038/nature14248
Ulirsch, J. C. et al. Interrogation of human hematopoiesis at single-cell and single-variant resolution. Nat. Genet. 51, 683–693 (2019).
pubmed: 30858613 pmcid: 6441389 doi: 10.1038/s41588-019-0362-6
Pliner, H. A. et al. Cicero predicts cis-regulatory DNA interactions from single-cell chromatin accessibility data. Mol. Cell 71, 858–871 e8 (2018).
pubmed: 30078726 pmcid: 6582963 doi: 10.1016/j.molcel.2018.06.044
Groopman, E. E. et al. Diagnostic utility of exome sequencing for kidney disease. N. Engl. J. Med. 380, 142–151 (2019).
pubmed: 30586318 doi: 10.1056/NEJMoa1806891
Wu, Y. et al. Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits. Nat. Commun. 9, 918 (2018).
pubmed: 29500431 pmcid: 5834629 doi: 10.1038/s41467-018-03371-0
Nasser, J. et al. Genome-wide enhancer maps link risk variants to disease genes. Nature 593, 238–243 (2021).
pubmed: 33828297 pmcid: 9153265 doi: 10.1038/s41586-021-03446-x
Freshour, S. L. et al. Integration of the drug-gene interaction database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 49, D1144–D1151 (2021).
pubmed: 33237278 doi: 10.1093/nar/gkaa1084
Guo, D. et al. Selective inhibition on organic cation transporters by carvedilol protects mice from cisplatin-induced nephrotoxicity. Pharm. Res. 35, 204 (2018).
pubmed: 30191328 pmcid: 6295285 doi: 10.1007/s11095-018-2486-2
Sarhan, M., von Mässenhausen, A., Hugo, C., Oberbauer, R. & Linkermann, A. Immunological consequences of kidney cell death. Cell Death Dis. 9, 114 (2018).
pubmed: 29371597 pmcid: 5833784 doi: 10.1038/s41419-017-0057-9
Miao, N. et al. The cleavage of gasdermin D by caspase-11 promotes tubular epithelial cell pyroptosis and urinary IL-18 excretion in acute kidney injury. Kidney Int. 96, 1105–1120 (2019).
pubmed: 31405732 doi: 10.1016/j.kint.2019.04.035
Tsuda, M. et al. Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin. Mol. Pharmacol. 75, 1280–1286 (2009).
pubmed: 19332510 doi: 10.1124/mol.109.056242
Vilaysane, A. et al. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J. Am. Soc. Nephrol. 21, 1732–1744 (2010).
pubmed: 20688930 pmcid: 3013544 doi: 10.1681/ASN.2010020143
Xu, Y. et al. A role for tubular necroptosis in cisplatin-induced AKI. J. Am. Soc. Nephrol. 26, 2647–2658 (2015).
pubmed: 25788533 pmcid: 4625668 doi: 10.1681/ASN.2014080741
Mulay, S. R., Linkermann, A. & Anders, H. J. Necroinflammation in kidney disease. J. Am. Soc. Nephrol. 27, 27–39 (2016).
pubmed: 26334031 doi: 10.1681/ASN.2015040405
Gamazon, E. R. et al. Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation. Nat. Genet. 50, 956–967 (2018).
pubmed: 29955180 pmcid: 6248311 doi: 10.1038/s41588-018-0154-4
Li, Y. I. et al. RNA splicing is a primary link between genetic variation and disease. Science 352, 600–604 (2016).
pubmed: 27126046 pmcid: 5182069 doi: 10.1126/science.aad9417
Zhang, Z. et al. Genetic analyses support the contribution of mRNA N
pubmed: 32601472 pmcid: 7483307 doi: 10.1038/s41588-020-0644-z
Park, J. et al. Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science 360, 758–763 (2018).
pubmed: 29622724 pmcid: 6188645 doi: 10.1126/science.aar2131
Li, Y. et al. Integration of GWAS summary statistics and gene expression reveals target cell types underlying kidney function traits. J. Am. Soc. Nephrol. 31, 2326–2340 (2020).
pubmed: 32764137 pmcid: 7609008 doi: 10.1681/ASN.2020010051
Fairfax, B. P. et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 343, 1246949 (2014).
pubmed: 24604202 pmcid: 4064786 doi: 10.1126/science.1246949
Guan, Y. et al. Dnmt3a- and Dnmt3b-decommissioned fetal enhancers are linked to kidney disease. J. Am. Soc. Nephrol. 31, 765–782 (2020).
pubmed: 32127410 pmcid: 7191927 doi: 10.1681/ASN.2019080797
Miao, Z. et al. Single cell regulatory landscape of the mouse kidney highlights cellular differentiation programs and disease targets. Nat. Commun. 12, 2277 (2021).
pubmed: 33859189 pmcid: 8050063 doi: 10.1038/s41467-021-22266-1
Sveinbjornsson, G. et al. Rare mutations associating with serum creatinine and chronic kidney disease. Hum. Mol. Genet. 23, 6935–6943 (2014).
pubmed: 25082825 doi: 10.1093/hmg/ddu399
Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009).
pubmed: 19414839 pmcid: 2763564 doi: 10.7326/0003-4819-150-9-200905050-00006
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
pubmed: 17701901 pmcid: 1950838 doi: 10.1086/519795
Delaneau, O., Zagury, J.-F. & Marchini, J. Improved whole-chromosome phasing for disease and population genetic studies. Nat. Methods 10, 5 (2013).
pubmed: 23269371 doi: 10.1038/nmeth.2307
Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
pubmed: 19543373 pmcid: 2689936 doi: 10.1371/journal.pgen.1000529
Howie, B., Marchini, J. & Stephens, M. Genotype imputation with thousands of genomes. G3 1, 457–470 (2011).
pubmed: 22384356 pmcid: 3276165 doi: 10.1534/g3.111.001198
Zhou, W., Triche, T. J. Jr., Laird, P. W. & Shen, H. SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions. Nucleic Acids Res. 46, e123 (2018).
pubmed: 30085201 pmcid: 6237738
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinf. 12, 323 (2011).
doi: 10.1186/1471-2105-12-323
Fang, R. et al. Comprehensive analysis of single cell ATAC-seq data with SnapATAC. Nat. Commun. 12, 1337 (2021).
pubmed: 33637727 pmcid: 7910485 doi: 10.1038/s41467-021-21583-9
Stouffer, S. A., Suchman, E. A., Devinney, L. C., Star, S. A. & Williams Jr, R. M. The American Soldier: Adjustment during army life (Studies in Social Psychology in World War II) Vol. 1 (Princeton Univ. Press, 1949).
Chu, A. Y. et al. Multiethnic genome-wide meta-analysis of ectopic fat depots identifies loci associated with adipocyte development and differentiation. Nat. Genet. 49, 125–130 (2017).
pubmed: 27918534 doi: 10.1038/ng.3738
Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481–487 (2016).
pubmed: 27019110 doi: 10.1038/ng.3538
McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495–501 (2010).
pubmed: 20436461 pmcid: 4840234 doi: 10.1038/nbt.1630
Yang, J. et al. FTO genotype is associated with phenotypic variability of body mass index. Nature 490, 267–272 (2012).
pubmed: 22982992 pmcid: 3564953 doi: 10.1038/nature11401
Shabalin, A. A. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28, 1353–1358 (2012).
pubmed: 22492648 pmcid: 3348564 doi: 10.1093/bioinformatics/bts163
Stegle, O., Parts, L., Durbin, R. & Winn, J. A Bayesian framework to account for complex non-genetic factors in gene expression levels greatly increases power in eQTL studies. PLoS Comput. Biol. 6, e1000770 (2010).
pubmed: 20463871 pmcid: 2865505 doi: 10.1371/journal.pcbi.1000770
Ongen, H., Buil, A., Brown, A. A., Dermitzakis, E. T. & Delaneau, O. Fast and efficient QTL mapper for thousands of molecular phenotypes. Bioinformatics 32, 1479–1485 (2016).
pubmed: 26708335 doi: 10.1093/bioinformatics/btv722
Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA 100, 9440–9445 (2003).
pubmed: 12883005 pmcid: 170937 doi: 10.1073/pnas.1530509100
Han, B. & Eskin, E. Interpreting meta-analyses of genome-wide association studies. PLoS Genet. 8, e1002555 (2012).
pubmed: 22396665 pmcid: 3291559 doi: 10.1371/journal.pgen.1002555
Frankish, A. et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 47, D766–D773 (2019).
pubmed: 30357393 doi: 10.1093/nar/gky955
Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).
pubmed: 24830394 pmcid: 4022491 doi: 10.1371/journal.pgen.1004383
Giambartolomei, C. et al. A Bayesian framework for multiple trait colocalization from summary association statistics. Bioinformatics 34, 2538–2545 (2018).
pubmed: 29579179 pmcid: 6061859 doi: 10.1093/bioinformatics/bty147
Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).
pubmed: 29184056 pmcid: 5705698 doi: 10.1038/s41467-017-01261-5
Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).
pubmed: 19131956 doi: 10.1038/nprot.2008.211
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
pubmed: 30305743 pmcid: 6786975 doi: 10.1038/s41586-018-0579-z
Park, J. et al. Exome-wide evaluation of rare coding variants using electronic health records identifies new gene-phenotype associations. Nat. Med. 27, 66–72 (2021).
pubmed: 33432171 pmcid: 8775355 doi: 10.1038/s41591-020-1133-8
Bramer, G. R. International statistical classification of diseases and related health problems. Tenth revision. World Health Stat. Q. 41, 32–36 (1988).
pubmed: 3376487
Carroll, R. J., Bastarache, L. & Denny, J. C. R PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment. Bioinformatics 30, 2375–2376 (2014).
pubmed: 24733291 pmcid: 4133579 doi: 10.1093/bioinformatics/btu197
Li, Q., Peng, X., Yang, H., Wang, H. & Shu, Y. Deficiency of multidrug and toxin extrusion 1 enhances renal accumulation of paraquat and deteriorates kidney injury in mice. Mol. Pharm. 8, 2476–2483 (2011).
pubmed: 21991918 pmcid: 3230245 doi: 10.1021/mp200395f
Liu, H. et al. Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease (Data Set). figshare https://doi.org/10.6084/m9.figshare.15183495 (2022).
Liu, H. et al. Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease (Code). Zenodo https://doi.org/10.5281/zenodo.6392494 (2022).

Auteurs

Hongbo Liu (H)

Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA.
Institute of Diabetes Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, USA.
Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA.

Tomohito Doke (T)

Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA.
Institute of Diabetes Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, USA.
Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA.

Dong Guo (D)

Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, Baltimore, MD, USA.

Xin Sheng (X)

Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA.
Institute of Diabetes Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, USA.
Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA.

Ziyuan Ma (Z)

Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA.
Institute of Diabetes Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, USA.
Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA.

Joseph Park (J)

Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA.
Institute for Biomedical Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Ha My T Vy (HMT)

Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Girish N Nadkarni (GN)

Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The Hasso Plattner Institute of Digital Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The Mount Sinai Clinical Intelligence Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Amin Abedini (A)

Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA.
Institute of Diabetes Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, USA.
Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA.

Zhen Miao (Z)

Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA.
Institute of Diabetes Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, USA.
Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA.

Matthew Palmer (M)

Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, USA.

Benjamin F Voight (BF)

Institute of Diabetes Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, USA.
Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.
Institute of Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.

Hongzhe Li (H)

Department of Biostatistics, Epidemiology, and Informatics, and Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Christopher D Brown (CD)

Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA.

Marylyn D Ritchie (MD)

Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA.
Institute for Biomedical Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Yan Shu (Y)

Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, Baltimore, MD, USA.

Katalin Susztak (K)

Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA. ksusztak@pennmedicine.upenn.edu.
Institute of Diabetes Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, USA. ksusztak@pennmedicine.upenn.edu.
Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA. ksusztak@pennmedicine.upenn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH